Cited by 199Cancer survivorship and careChemotherapy-induced cardiotoxicity and mitigationChildhood Cancer Survivors' Quality of Life

Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

Open access
Denlinger, Crystal S., Sanft, Tara, Baker, K. Scott, Broderick, Gregory, Demark-Wahnefried, Wendy, Friedman, Debra L., Goldman, Mindy, Hudson, Melissa +26 more·2018·Journal of the National Comprehensive Cancer Network

Abstract

The NCCN Guidelines for Survivorship provide screening, evaluation, and treatment recommendations for common physical and psychosocial consequences of cancer and cancer treatment to help healthcare professionals who work with survivors of adult-onset cancer in the posttreatment period. This portion of the guidelines describes recommendations regarding the management of anthracycline-induced cardiotoxicity and lymphedema. In addition, recommendations regarding immunizations and the prevention of infections in cancer survivors are included.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.6004/jnccn.2018.0078

Cites

150 of 150 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Denlinger, C. S., Sanft, T., Baker, K. S., Broderick, G., Demark-Wahnefried, W., Friedman, D. L., Goldman, M., Hudson, M., Khakpour, N., King, A., Koura, D., Lally, R. M., Langbaum, T. S., McDonough, A. L., Melisko, M., Montoya, J. G., Mooney, K., Moslehi, J. J., O'Connor, T., Overholser, L., Paskett, E. D., Peppercorn, J., Pirl, W., Rodriguez, M. A., Ruddy, K. J., Silverman, P., Smith, S., Syrjala, K. L., Tevaarwerk, A., Urba, S. G., Wakabayashi, M. T., Zee, P., McMillian, N. R., & Freedman-Cass, D. A.
Affiliations
  • Fox Chase Cancer Center (US)
  • Yale Cancer Center (US)
  • Seattle Cancer Care Alliance (US)
  • Barnes-Jewish Hospital (US)
  • UCSF Helen Diller Family Comprehensive Cancer Center (US)
  • Moffitt Cancer Center (US)
  • Moores Cancer Center (US)
  • Fred and Pamela Buffett Cancer Center (US)
  • Johns Hopkins University (US)
  • Massachusetts General Hospital (US)
  • Vanderbilt University (US)
  • University of Colorado Cancer Center (US)
  • The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US)
  • Dana-Farber Brigham Cancer Center (US)
  • Cleveland Clinic (US)
  • Duke University (US)
  • University of Wisconsin–Madison (US)
  • City Of Hope National Medical Center (US)
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University (US)
Venue
Journal of the National Comprehensive Cancer Network
Published
2018-10
Volume
16
Issue
10
Pages
1216-1247
ISSN
  • 1540-1405 (ISSN-L)
  • 1540-1413
OpenAlex
W2896465321
Cited by
199
References
150
Citations by year
2026: 9 · 2025: 12 · 2024: 23 · 2023: 11 · 2022: 40 · 2021: 25 · 2020: 40 · 2019: 28 · 2018: 4 · 2017: 3 · 2016: 3 · 2015: 1
FWCI
9.09
Type
journal article
Language
en
Open access
Locations
  • Journal of the National Comprehensive Cancer Network (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
National Cancer Institute (R01CA215134)
Topics
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
Keywords
cancer survivorship, anthracycline cardiotoxicity, lymphedema, immunization, infection control, adult-onset cancer
MeSH terms
Cancer Survivors, Survivorship, Antineoplastic Agents, Immunological, Antibiotics, Antineoplastic, Bacterial Infections, Humans, Lymphedema, Mass Screening, Medical Oncology, Neoplasms, Societies, Medical, United States, Vaccination, Virus Diseases, Immunocompromised Host, Risk Assessment, Anthracyclines, Cardiotoxicity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review